atomoxetine hydrochloride has been researched along with Depression, Involutional in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aldosary, F; Blier, P; James, JS; Norris, S; Ritchie, JC; Tremblay, P | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
| Gandhi, R; Lippmann, S; Narang, P | 1 |
| Adler, LA; Amsterdam, JD; Dunner, DL; Michelson, D; Nierenberg, AA; Reimherr, FW; Schatzberg, AF; Williams, D | 1 |
| Allen, AJ; D'souza, DN; Emslie, GJ; Kratochvil, C; Newcorn, JH; Schuh, LM; Sutton, VK; Wilens, T; Zhang, S | 1 |
| Howland, RH | 1 |
| Daviss, SR; Sawant, S | 1 |
| Burns, AM; Fava, M; Papakostas, GI; Petersen, TJ | 1 |
| Adli, M; Bauer, M; Burghardt, R; Pilhatsch, MK; Wandinger, KP | 1 |
| Dewan, M; Faraone, SV; Kunwar, A | 1 |
| Adler, LA; Amsterdam, JD; Dunner, DL; Kelsey, DK; Michelson, D; Nierenberg, AA; Reimherr, FW; Schatzberg, AF; Williams, DW | 1 |
| Allen, AJ; Bangs, ME; Bartky, EJ; Busner, J; Carlson, C; Duesenberg, DA; Emslie, GJ; Harshawat, P; Kaplan, SL; Quintana, H; Ramsey, JL; Spencer, TJ; Sumner, CR | 1 |
2 review(s) available for atomoxetine hydrochloride and Depression, Involutional
| Article | Year |
|---|---|
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Personality Assessment; Placebo Effect; Propylamines; Randomized Controlled Trials as Topic; Research Design | 2009 |
Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Comorbidity; Depressive Disorder, Major; Humans; Mental Disorders; Prevalence; Propylamines | 2007 |
3 trial(s) available for atomoxetine hydrochloride and Depression, Involutional
| Article | Year |
|---|---|
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Odds Ratio; Propylamines; Recurrence; Sertraline; Tachyphylaxis; Treatment Outcome | 2009 |
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Propylamines; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2007 |
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Nausea; Propylamines; Psychiatric Status Rating Scales; Severity of Illness Index | 2007 |
7 other study(ies) available for atomoxetine hydrochloride and Depression, Involutional
| Article | Year |
|---|---|
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
Topics: Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Cyclohexanols; Depressive Disorder, Major; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride | 2022 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |
Urinary Hesitancy Associated With Atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Humans; Male; Urinary Retention | 2017 |
The use of dopaminergic and stimulant drugs for the treatment of depression.
Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Therapy, Combination; Epinephrine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Norepinephrine; Propylamines | 2012 |
Seizures and prolonged QTc with atomoxetine overdose.
Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Depressive Disorder, Major; Drug Overdose; Humans; Long QT Syndrome; Male; Propylamines; Seizures | 2004 |
Adjunctive atomoxetine for residual fatigue in major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Depressive Disorder, Major; Drug Therapy, Combination; Fatigue; Female; Humans; Male; Propylamines; Retrospective Studies | 2006 |
Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Nortriptyline; Propylamines; Psychotic Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2006 |